Measurable Actions

The following table shows the topics presented in this EQIPP course, the measurable actions associated with each topic, and the health supervision visit age when these actions should occur.

KCA: Family Concerns and Engagement
Topic	Measurable Actions	Timing
Patient/Family Concerns	Elicit and address.	All health supervision visits
Family Strengths	Identify and discuss.	All health supervision visits
Anticipatory Guidance on Bright Futures Priorities	Counsel and discuss educational materials provided.	All health supervision visits
Social Determinants (Drivers) of Health	Assess and address.	All health supervision visits

KCA: Preventive Care Activities and Services
Topic	Measurable Actions	Timing
Perinatal Depression	Screen and follow-up on positive screens.	By 1 month and at 2-, 4-, and 6-month visits
Developmental Screening and Surveillance	Screen and follow-up on positive screens.	Surveillance: All health supervision visits Screening: 9-, 18-, 30-month visits
Growth Weight for Length and Head Circumference <2 yrs BMI ≥2 yrs	Measure/plot and follow-up on growth concerns.	All health supervision visits
Immunization Status	Verify and address missed vaccines.	All health supervision visits
Oral Health	Provide oral health risk assessment and follow-up (includes recommendation to a dental home and fluoride application).	All health supervision visits
Autism Spectrum Specific Disorder	Screen and follow up on positive screens.	18- and 24-month visits
Age-appropriate Risk Assessment	Assess risk and follow up on positive assessments.	All health supervision visits
Behavioral-Social-Emotional Screening	Assess and follow up on positive screening.	All health supervision visits
Lipid	Screen and follow up on positive screens.	At least once for patients ages 9–11 years; (and at least once for patients ages 17–21 years)
Substance Use	Screen and follow- p on positive screens.	Annually for patients ages 11–21 years
Adolescent Depression and Suicide Risk	Screen and follow up on positive screens.	Annually for patients ages 12–21 years
HIV	Screen and follow up on positive screens.	At least once for patients ages 15–18 years (more often if risk factors are present)
Chlamydia	Screen and follow up on positive screens.	Annually for patients ages 11–21 years who are female and sexually active or male who are sexually active and at increased risk